Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Explorative, Double-blind Study on Dose Effectiveness of DUROGESIC D-Trans 12 Mcg/h and 25mcg/h Compared to Transtec and Placebo in Acute Pain Models in Healthy Volunteers.

NCT00886002 is registered in ClinicalTrials.gov with Janssen-Cilag A.G., Switzerland as lead sponsor.

NCT NCT00886002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00886002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Explorative, Double-blind Study on Dose Effectiveness of DUROGESIC D-Trans 12 Mcg/h and 25mcg/h Compared to Transtec and Placebo in Acute Pain Models in Healthy Volunteers.
Lead sponsor
Janssen-Cilag A.G., Switzerland
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2004
Completion date
January 31, 2005
Enrollment
20 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pain